Price History
Feb 9, 2026 — Aug 16, 2026Investment Snapshot
- Trading 887% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 5/9 — moderate financial health
- ROE of 3.0% — below-average profitability
- Revenue growing at 13% annually
Warby Parker Inc. Class A Common Stock (WRBY) is a Healthcare company operating in Ophthalmic Goods, listed on the NYSE , with a market capitalisation of $3.2 billion . Key value metrics: P/E ratio 268.3, P/B ratio 8.18, Piotroski F-Score 5 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Warby Parker Inc. Class A Common Stock — Fundamental Analysis Summary
Warby Parker Inc. Class A Common Stock (WRBY) is currently trading 887% above its Graham Number of $2.62, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 268.3x.
On financial health, WRBY shows a moderate Piotroski F-Score of 5/9, and modest return on equity of 3.0% (sector average: -20.1%), and manageable leverage with a debt-to-equity ratio of 0.96.
StockPik's composite Value Score for WRBY is 44/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
WRBY reports a solid gross margin of 54.8% (sector average: 37.4%) and a modest operating margin of 0.4%.
WRBY shows revenue growing at 13% year-over-year, with earnings growing at 108%.